Strategies to query and display allergy-derived epitope data from the immune epitope database

International Archives of Allergy and Immunology

Volumn 160, Issue 4, 2013, Pages 334-345

  Vaughan, Kerrie ^c   Peters, Bjoern ^c   Larche, Mark ^d   Pomes, Anna ^a   Broide, David ^b   Sette, Alessandro ^c  

^a INDOOR Biotechnologies Inc   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Allergen; Allergy; Database; Epitope

Indexed keywords

ALLERGEN; EPITOPE; IMMUNOGLOBULIN E; BETA LACTOGLOBULIN; CASEIN;

ALLERGIC DISEASE; ALLERGIC REACTION; ALLERGY; AMINO ACID SEQUENCE; ARTICLE; ASSAY; CRYSTAL STRUCTURE; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOPATHOLOGY; IMMUNOTHERAPY; NOMENCLATURE; PRIORITY JOURNAL; REFERENCE DATABASE; T LYMPHOCYTE; TAXONOMY; X RAY CRYSTALLOGRAPHY; AUTOIMMUNITY; B LYMPHOCYTE; BLATTELLA GERMANICA; CONTACT DERMATITIS; DATA BASE; DRUG HYPERSENSITIVITY; EPITOPE MAPPING; FOOD ALLERGY; NONHUMAN; REVIEW;

ALLERGENS; ANIMALS; CRYSTALLOGRAPHY, X-RAY; DATA DISPLAY; DATABASES, FACTUAL; DATABASES, PROTEIN; DESENSITIZATION, IMMUNOLOGIC; EPITOPES; EPITOPES, T-LYMPHOCYTE; HUMANS; HYPERSENSITIVITY; LYMPHOCYTE ACTIVATION; PEPTIDES; PROTEINS; T-LYMPHOCYTES;

EID: 84869216707     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000343880     Document Type: Article

References (63)

1. Akdis CA: Allergy and hypersensitivity: mechanisms of allergic disease. Curr Opin Immunol 2006; 18: 718-726.
2. Haselden BM, Kay AB, Larche M: Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope- induced late asthmatic reactions. J Exp Med 1999; 189: 1885-1894.
3. Ali FR, Oldfield WL, Higashi N, Larche M, Kay AB: Late asthmatic reactions induced by inhalation of allergen-derived T cell peptides. Am J Respir Crit Care Med 2004; 169: 20-26.
4. Akdis CA, Akdis M: Mechanisms of allergen- specific immunotherapy. J Allergy Clin Immunol 2011; 127: 18-27.
5. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C: Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific Tcell tolerance, and immune deviation. J Allergy Clin Immunol 2007; 120: 707-713.
6. Verhoef A, Alexander C, Kay AB, Larche M: T cell epitope immunotherapy induces a CD4(+) T cell population with regulatory Activity. PLoS Med 2005; 2:e78.
7. Francis JN, Till SJ, Durham SR: Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003; 111: 1255-1261.
8. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K: Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998; 102: 98-106.
9. Bellinghausen I, Metz G, Enk AH, Christmann S, Knop J, Saloga J: Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 1997; 27: 1131-1139.
10. Ebner C, Siemann U, Bohle B, Willheim M, Wiedermann U, Schenk S et al: Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin Exp Allergy 1997; 27: 1007-1015.
11. Varney VA, Hamid QA, Gaga M, Ying S, Jacobson M, Frew AJ, et al: Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993; 92: 644-651.
12. James LK, Shamji MH, Walker SM, Wilson DR, Wachholz PA, Francis JN et al: Longterm tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol 2011; 127: 509-516.
13. Wachholz PA, Soni NK, Till SJ, Durham SR: Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy. J Allergy Clin Immunol 2003; 112: 915-922.
14. Levy DA, Lichtenstein LM, Goldstein EO, Ishizaka K: Immunologic and cellular changes accompanying the therapy of pollen allergy. J Clin Invest 1971; 50: 360-369.
15. Durham SR: Allergen immunotherapy: 100 years on. Clin Exp Allergy 2011; 41: 1171.
16. Ring J, Gutermuth J: 100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT). Allergy 2011; 66: 713-724.
17. Larche M: T cell epitope-based allergy vaccines. Curr Top Microbiol Immunol 2011; 352: 107-119.
18. Tanabe S: Epitope peptides and immunotherapy. Curr Protein Peptide Sci 2007; 8: 109-118.
19. Larche M, Wraith DC: Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med 2005; 11:S69-S76.
20. Glesner J, Wünschmann S, Li M, Gustchina A, Wlodawer A, Himly M, Chapman MD, Pomés A: Mechanisms of allergen-antibody interaction of cockroach allergen Bla g 2 with monoclonal antibodies that inhibit IgE antibody binding. PLoS One 2011; 6:e22223.
21. Neudecker P, Lehmann K, Nerkamp J, Haase T, Wangorsch A, Fotisch K et al: Mutational epitope analysis of Pru av 1 and Api g 1, the major allergens of cherry (Prunus avium) and celery (Apium graveolens): correlating IgE reactivity with three-dimensional structure. Biochem J 2003; 376: 97-107.
22. Gafvelin G, Parmley S, Neimert-Andersson T, Blank U, Eriksson TL, van HM et al: Hypoallergens for allergen-specific immunotherapy by directed molecular evolution of mite group 2 allergens. J Biol Chem 2007; 282: 3778-3787.
23. Flicker S, Steinberger P, Norderhaug L, Sperr WR, Majlesi Y, Valent P, et al: Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody. Eur J Immunol 2002; 32: 2156-2162.
24. Edlmayr J, Niespodziana K, Linhart B, Focke- Tejkl M, Westritschnig K, Scheiblhofer S, et al: A combination vaccine for allergy and rhinovirus infections based on rhinovirus- derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1. J Immunol 2009; 182: 6298-6306.
25. Niespodziana K, Focke-Tejkl M, Linhart B, Civaj V, Blatt K, Valent P, et al: A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS. J Allergy Clin Immunol 2011; 127: 1562-1570.
26. van Milligen FJ, van 't HW, van den BM, Aalberse RC: IgE epitopes on the cat (Felis domesticus) major allergen Fel d I: a study with overlapping synthetic peptides. J Allergy Clin Immunol 1994; 93: 34-43.
27. Wallmann J, Proell M, Stepanoska T, Hantusch B, Pali-Scholl I, Thalhamer T et al: A mimotope gene encoding the major IgE epitope of allergen Phl p 5 for epitope-specific immunization. Immunol Lett 2009; 122: 68-75.
28. Holmgren J, Czerkinsky C: Mucosal immunity and vaccines. Nat Med 2005; 11:S45- S53.
29. Jenkins JA, Griffiths-Jones S, Shewry PR, Breiteneder H, Mills EN: Structural relatedness of plant food allergens with specific reference to cross-reactive allergens: an in silico analysis. J Allergy Clin Immunol 2005; 115: 163-170.
30. Ferreira F, Hawranek T, Gruber P, Wopfner N, Mari A: Allergic cross-reactivity: from gene to the clinic. Allergy 2004; 59: 243-267.
31. Ayuso R, Reese G, Leong-Kee S, Plante M, Lehrer SB: Molecular basis of arthropod cross-reactivity: IgE-binding cross-reactive epitopes of shrimp, house dust mite and cockroach tropomyosins. Int Arch Allergy Immunol 2002; 129: 38-48.
32. Scheurer S, Son DY, Boehm M, Karamloo F, Franke S, Hoffmann A, Haustein D, Vieths S: Cross-reactivity and epitope analysis of Pru a 1, the major cherry allergen. Mol Immunol 1999; 36: 155-167.
33. Pomés A: Relevant B cell epitopes in allergic disease. Int Arch Allergy Immunol 2010; 152: 1-11.
34. Goodman RE, Vieths S, Sampson HA, Hill D, Ebisawa M, Taylor SL, van Ree R: Allergenicity assessment of genetically modified crops - what makes sense? Nature Biotech 2008; 26: 73-81.
35. Aalberse RC: Assessment of allergen crossreactivity, Clin Mol Allergy 2007; 5: 2.
36. Aalberse RC, Crameri R: IgE-binding epitopes: a reappraisal. Allergy 2011; 66: 1261-1274.
37. Van OL, Wambre E, Maillere B, Von HE, Louise A, Balazuc AM, et al: Assessment of Bet v 1-specific CD4+ T cell responses in allergic and nonallergic individuals using MHC class II peptide tetramers. J Immunol 2008; 180: 4514-4522.
38. Wambre E, DeLong JH, James EA, LaFond RE, Robinson D, Kwok WW: Differentiation stage determines pathologic and protective allergen specific CD4+ T-cell outcomes during specific immunotherapy. J Allergy Clin Immunol 2012; 129: 544-551.
39. James EA, Kwok WW: Autoreactive CD4(+) T cells in patients with atopic dermatitis. J Allergy Clin Immunol 2011; 128: 100-101.
40. DeLong JH, Simpson KH, Wambre E, James EA, Robinson D, Kwok WW: Ara h1-reactive T cells in individuals with peanut allergy. J Allergy Clin Immunol 2011; 127: 1211-1218.
41. Bonvalet M, Wambre E, Moussu H, Horiot S, Kwok WW, Louise A, Ebo D, Hoarau C, Van Overtvelt L, Baron-Bodo V, Moingeon P: Comparison between major histocompatibility complex class II tetramer staining and surface expression of activation markers for the detection of allergen-specific CD4+ T cells. Clin Exp Allergy 2011; 41: 821-829.
42. Kwok WW, Roti M, Delong JH, Tan V, Wambre E, James EA, Robinson D: Direct ex vivo analysis of allergen-specific CD4+ T cells. J Allergy Clin Immunol 2010; 125: 1407-1409.
43. Oseroff C, Sidney J, Kotturi MF, Kolla R, Alam R, Broide DH, Wasserman SI, Weiskopf D, McKinney DM, Chung JL, Petersen A, Grey H, Peters B, Sette A: Molecular determinants of T cell epitope recognition to the common Timothy grass allergen. J Immunol 2010; 185: 943-955.
44. Kinnunen T, Nieminen A, Kwok WW, Närvänen A, Rytkönen-Nissinen M, Saarelainen S, Taivainen A, Virtanen T: Allergenspecific naive and memory CD4+ T cells exhibit functional and phenotypic differences between individuals with or without allergy. Eur J Immunol 2010; 40: 2460-2469.
45. Kinnunen T, Jutila K, Kwok WW, Rytkönen- Nissinen M, Immonen A, Saarelainen S, Närvänen A, Taivainen A, Virtanen T: Potential of an altered peptide ligand of lipocalin allergen Bos d 2 for peptide immunotherapy. J Allergy Clin Immunol 2007; 119: 965-972.
46. Macaubas C, Wahlstrom J, Galvão da Silva AP, Forsthuber TG, Sønderstrup G, Kwok WW, DeKruyff RH, Umetsu DT: Allergenspecific MHC class II tetramer+ cells are detectable in allergic, but not in non-allergic, individuals. J Immunol 2006; 176: 5069-5077.
47. Kinnunen T, Kwok WW, Närvänen A, Rytkönen- Nissinen M, Immonen A, Saarelainen S, Taivainen A, Virtanen T: Immunomodulatory potential of heteroclitic analogs of the dominant T-cell epitope of lipocalin allergen Bos d 2 on specific T cells. Int Immunol 2005; 17: 1573-1581.
48. Campbell JD, Buckland KF, McMillan SJ, Kearley J, Oldfield WL, Stern LJ et al: Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J Exp Med 2009; 206: 1535-1547.
49. Commins SP, Platts-Mills TA: Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant. J Allergy Clin Immunol 2009; 124: 652-657.
50. Vita R, Peters B, Josephs Z, de Matos P, Ennis M, Turner S, Steinbeck C, Seymour E, Zarebski L, Sette A: A Model for collaborative curation, The IEDB and ChEBI curation of non-peptidic epitopes. Immunome Res 2011; 7: 1-8.
51. Padavattan et al. Padavattan S, Flicker S, Schirmer T, Madritsch C, Randow S, Reese G, Vieths S, Lupinek C, Ebner C, Valenta R, Markovic-Housley Z: High-affinity IgE recognition of a conformational epitope of the major respiratory allergen Phl p 2 as revealed by X-ray crystallography. J Immunol 2009; 182: 2141-2151.
52. Beaver JE, Bourne PE, Ponomarenko JV: EpitopeViewer: a Java application for the visualization and analysis of immune epitopes in the Immune Epitope Database and Analysis Resource (IEDB). Immunome Res 2007; 3: 3.
53. King TP, Hoffman D, Lowenstein H, Marsh DG, Platts-Mills TA, Thomas W: Allergen nomenclature: WHO/IUIS Allergen Nomenclature Subcommittee. Int Arch Allergy Immunol 1994; 105: 224-233.
54. Kim Y, Vaughan K, Greenbaum J, Peters B, Law M, Sette A: A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV). PLoS One 2012; 7:e38028.
55. Niemi M, Jylhä S, Laukkanen ML, Söderlund H, Mäkinen-Kiljunen S, Kallio JM, Hakulinen N, Haahtela T, Takkinen K, Rouvinen J: Molecular interactions between a recombinant IgE antibody and the beta-lactoglobulin allergen. Structure 2007; 15: 1413-1421.
56. Mirza O, Henriksen A, Ipsen H, Larsen JN, Wissenbach M, Spangfort MD, Gajhede M: Dominant epitopes and allergic cross-reactivity: complex formation between a Fab fragment of a monoclonal murine IgG antibody and the major allergen from birch pollen Bet v 1. J Immunol 2000; 165: 331-338.
57. Padavattan S, Schirmer T, Schmidt M, Akdis C, Valenta R, Mittermann I, Soldatova L, Slater J, Mueller U, Markovic-Housley Z: Identification of a B-cell epitope of hyaluronidase, a major bee venom allergen, from its crystal structure in complex with a specific Fab. J Mol Biol 2007; 368: 742-752.
58. Li M, Gustchina A, Alexandratos J, Wlodawer A, Wünschmann S, Kepley CL, Chapman MD, Pomés A: Crystal structure of a dimerized cockroach allergen Bla g 2 complexed with a monoclonal antibody. J Biol Chem 2008; 283: 22806-22814.
59. Li M, Gustchina A, Glesner J, Wünschmann S, Vailes LD, Chapman MD, Pomés A, Wlodawer A: Carbohydrates contribute to the interactions between cockroach allergen Bla g2 and a monoclonal antibody. J Immunol 2011; 186: 333-340.
60. Chruszcz M, Chapman MD, Vailes LD, Stura EA, Saint-Remy JM, Minor W, Pomés A: Crystal structures of mite allergens Der f 1 and Der p 1 reveal differences in surface-exposed residues that may influence antibody binding. J Mol Biol 2009; 386: 520-530.
61. Worm M, Lee HH, Kleine-Tebbe J, Hafner RP, Laidler P, Healey D, et al: Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy. J Allergy Clin Immunol 2011; 127: 89-97.
62. Vercelli D: Remembrance of things past: HLA genes come back on the allergy stage. Allergy Clin Immunol 2012; 129: 846-847.
63. Vaughan K, Greenbaum J, Kim Y, Vita R, Chung J, Peters B, Broide D, Goodman R, Grey H, Sette A: Towards defining molecular determinants recognized by adaptive immunity in allergic disease: an inventory of the available data. J Allergy (Cairo) 2010; 2010: 628026.